The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
about
A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2Genomic approaches in breast cancer researchAdjuvant radiotherapy in breast cancer--the treatment of lymph node areas.Preoperative assessment of prognostic factors in breast cancer.Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic valueStatistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumorsThrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.Is apocrine differentiation in breast carcinoma of prognostic significance?The immunocytochemical detection of axillary micrometastases in breast cancer.Tumour aneuploidy, prognostic parameters and survival in primary breast cancerConfirmation of a prognostic index in primary breast cancer.Histopathology of breast cancer in relation to age.Social class and weight as prognostic factors in early breast cancerInflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patientsClinicopathological characteristics of infiltrating lobular breast carcinoma in elderly women: Preliminary results.Mucoid breast carcinomas: histology and prognosis.Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumours.An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodesWest Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy data.Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.Angiogenesis and inflammation in invasive carcinoma of the breast.Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.Cytokeratin intermediate filament expression in benign and malignant breast disease.Heterogeneity of invasive ductal carcinoma: proposal for a hypothetical classification.Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.Screening for breast cancer: some clinical aspects.Is radiation therapy in conjunction with mastectomy indicated for the treatment of operable breast cancer?Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.Long-term follow-up of sickness periods in breast cancer patients primarily treated with surgery and radiotherapy or surgery only.The role of histologic grading in the prognosis of patients with carcinoma of the breast: is this a neglected opportunity?p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.
P2860
Q24685409-0D384B3E-49A9-48E5-8FD2-04185DE008EFQ26865893-B57BE230-2EE6-44C5-BCFB-1B21B06316BAQ34033287-9D7E79AB-14EB-4701-8DA4-935A8A505A01Q34197110-DDCE3DEE-0F8E-439A-87FA-DF034F536E0FQ34489356-BC970AA2-1F4A-4D94-B083-D3D1A6E7768CQ35070178-8D7E0CDF-A544-4DD8-9697-094C7875AC08Q35168065-0613DCDA-CBCA-4BA4-B0BC-7F0C1CDD1DBAQ35747316-0C3E4E0D-97A4-4523-907C-D0F03A280799Q35831750-793BC4B5-9A59-4516-9FA6-30C174F091E1Q35981934-0B1F05C9-EADF-4DD4-8023-848FA4C61F8BQ35982514-03F16D97-70DC-42C2-B1B4-A7ED3EE2A23CQ35982863-13769835-6170-4497-9DED-CD73BFF6D540Q35991722-83344EAC-B359-4EC2-9965-EF18ED1C9470Q36027971-CB4568FE-E491-40F9-8C45-24D87577D3CCQ36028322-CEF9A727-9FF6-4AA8-8628-0ABD8E352E09Q36116041-2F95BDCE-27F6-43E8-91C0-7C7670C8ED7CQ36116206-262BB84A-B300-478F-8FA0-D0D70A60426BQ36136011-309281D9-D2D5-45AC-B18D-915AFE466311Q36285962-A564D34A-F510-462B-A0C6-0B5B86627871Q36334686-E70EEC8E-E14B-4F6F-A570-5F104138FD00Q36420076-4B42EEF7-AE82-442A-88B1-92C4DAE72277Q36465780-3C22C0A6-0F24-4170-8DD7-21AE2A597A73Q36467701-714FC230-AF10-4D62-BC23-411C7B97FA63Q36467816-5CCE2486-CB02-403A-AA5D-F2BEFCD25CD1Q36467888-AA75DEC2-FCE6-492A-93D0-D3C4EC1A51EFQ36601299-9FA155F4-4DAF-4523-9335-CACF3666B80FQ36692392-6A92D4EF-1E23-42A7-B919-E4796C9BFD37Q37210559-B1F72CD4-8D08-491B-9F28-A34C2256A4EAQ37234841-0E513309-C08E-475C-ABD7-DA45E013F7AFQ37255237-144A7609-0074-405F-ADB2-854B4DBDAD12Q37313341-21FD8893-D90B-4C78-AD5A-6C614D4D7051Q38488717-248B0996-6791-4661-AC41-073C4CAD5117Q38489173-9B065750-CEE9-4BAC-A82F-2429F006A94DQ39255735-2A5F65F7-0B6F-41F2-AD47-CF636BCA2312Q39668860-AE320854-8869-41E3-88CF-150A5A159282Q39747830-D04CCC69-DE89-425C-A5BA-06D0D9E97998Q40819797-E0B69559-B209-4380-B1B2-39C916D8984FQ41301897-018C2FB7-78F3-4070-A481-A4F0D1A3F4CDQ41627632-AD749A33-6A53-4CB9-8205-1DB2612E3746Q42033809-F8F99669-8912-4B09-A3C2-1FF41F5F666E
P2860
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The cancer research campaign ( ...... clinico-pathological aspects.
@ast
The cancer research campaign ( ...... clinico-pathological aspects.
@en
type
label
The cancer research campaign ( ...... clinico-pathological aspects.
@ast
The cancer research campaign ( ...... clinico-pathological aspects.
@en
prefLabel
The cancer research campaign ( ...... clinico-pathological aspects.
@ast
The cancer research campaign ( ...... clinico-pathological aspects.
@en
P2093
P2860
P356
P1476
The cancer research campaign ( ...... clinico-pathological aspects.
@en
P2093
Gresham GA
Haybittle JL
Houghton J
P2860
P2888
P304
P356
10.1038/BJC.1982.106
P407
P577
1982-05-01T00:00:00Z